The WHO estimates of excess mortality associated with the COVID-19 pandemic.

Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. · 2023

Read The WHO estimates of excess mortality associated with the COVID-19 pandemic. by Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9812776.txt.

Introduction

Msemburi and co-authors present the World Health Organization estimates of excess deaths from the COVID-19 pandemic. Reported COVID-19 death counts were shaky in many countries. Testing access, diagnosis skill, and death papers all varied. Collateral harm from the crisis also killed people unseen.

The team estimated excess deaths month by month for two years. The window covered 2020 and 2021 across the globe. A Bayesian count model filled gaps where data were missing. Global excess deaths came to more than 14 million people. That toll ran nearly three times the reported COVID-19 deaths. Estimates varied widely across the six WHO regions. The authors describe their data and methods in full. They warn against ranking countries by these numbers. Better death reporting is their closing call to governments.

Catalog record

CREATORMsemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE74 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9812776

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The WHO estimates of excess mortality associated with the COVID-19 pandemic By William Msemburi, Ariel Karlinsky, Victoria Knutson, Serge Aleshin-Guendel, Somnath Chatterji, Jon Wakefield Published in: Nature DOI: 10.1038/s41586-022-05522-2 ABSTRACT Abstract The World Health Organization has a mandate to compile and disseminate statistics on mortality, and we have been tracking the progression of the COVID-19 pandemic since the beginning of 20201. Reported statistics on COVID-19 mortality are problematic for many countries owing to variations in testing access, differential diagnostic capacity and inconsistent certification of COVID-19 as cause of death. Beyond what is directly attributable to it, the pandemic has caused extensive collateral damage that has led to losses of lives and livelihoods. Here we report a comprehensive and consistent measurement of the impact of the COVID-19 pandemic by estimating excess deaths, by month, for 2020 and 2021. We predict the pandemic period all-cause deaths in locations lacking complete reported data using an overdispersed Poisson count framework that applies Bayesian inference techniques to quantify uncertainty. We estimate 14.83 million excess deaths globally, 2.74 times more deaths than the 5.42 million reported as due to COVID-19 for the period. There are wide variations in the excess death estimates across the six World Health Organization regions. We describe the data and methods used to generate these estimates and highlight the need for better reporting where gaps persist. We discuss various summary measures, and the hazards of ranking countries’ epidemic responses. Subject terms: Epidemiology, Social sciences MAIN The COVID-19 pandemic caught the world unprepared, and it has exacted a toll many would have considered inconceivable in the modern era before its emergence. As of 31 December 2021, more than 287 million confirmed cases of COVID-19 across the world had been reported to the World Health Organization (WHO) including 5.4 million deaths (https://covid19.who.int/). From the documenting of initial COVID-19 cases in Wuhan, China in December of 2019 through to the WHO declaring it a pandemic in March of 20201, accurately tracking COVID-19 and its impact has been riddled with challenges. An initial major challenge was developing the diagnostic tools to correctly identify the presence of the virus. A number of countries relied on pre-existing platforms to achieve this and they quickly adapted and scaled up the available technologies to allow for COVID-19 testing. However, many countries lacked such capacity. In addition, countries have differed in their application of standards for the certification of COVID-19 as the underlying cause-of-death2. This has caused both country-level and worldwide assessment of the spread and impact of the pandemic to be incomplete. An estimate of the excess mortality associated with the COVID-19 pandemic is therefore a better measure of the overall impact of the crisis. Excess mortality is defined as, “The difference in the total number of deaths in a crisis compared to those expected under normal conditions”3. Excess mortality accounts for both the total number of deaths directly attributed to the virus and those resulting from the indirect impact, such as disruption to essential health services or travel disruptions4. Excess mortality is a well established concept dating back centuries5, and has been used extensively to estimate the toll of past health crises and pandemics such as the 1918 ‘Spanish Flu’6. The measure overcomes the variation among countries in reporting and testing and the misclassification of the cause of death on death certificates7 and requires only information on the total number of deaths during the health crisis, and before, to establish the expected number of deaths. Unfortunately, excess mortality cannot be directly estimated for all countries owing to many not having the requisite all-cause mortality (ACM) data. The WHO usually receives routine mortality data on an annual basis following the year of death or after an even longer lag. Civil registration and vital statistics (CRVS) systems differ across countries with varying completeness, timeliness and quality control measures for compiling unit record cause of death numbers into aggregates identified by cause, age, sex, place and period of death8–11. Moreover, differential reporting coverage, the absence of electronic surveillance systems in some locations and limited investments in CRVS systems has resulted in many nations lacking the structures necessary to provide good-quality routine data, even before the onset of the pandemic. Correspondingly, they lack the capacity and data required to monitor ACM during this unprecedented pandemic. This results in numerous countries being unable to contribute to the centralized systematic mortality surveillance that would be necessary for the WHO to measure global-, regional- and country-level excess mortality. Acknowledging these data gaps, a model-based framework, relying on ACM information from countries for which data exist and other relevant factors, has been developed by the WHO. The purpose of this framework is to estimate country, regional and global excess deaths from 1 January 2020 to 31 December 2021 on a monthly timescale. PROCESS, METHODS AND DATA Detailed descriptions of the process followed, data used and methods applied to generate the estimates of excess mortality within this paper are provided in the Methods and summarized here. The WHO, in collaboration with the United Nations Department of Economic and Social Affairs, assembled a technical advisory group to develop guidance on how to best estimate excess mortality in light of extensive data gaps. Preliminary estimates were generated according to the advice of this group and, following standard WHO procedures, a consultative process was initiated with member states who assessed the input data sources, methods and results, and provided feedback which was in turn used to update the estimates. Ideally, we would have ACM data for all countries and for all months. The reality is that such monthly national data are available for only 100 countries (52%), with other countries having annual data, subnational data or no data. For the latter three cases, we predict the monthly data within a Poisson count model framework, as detailed in the Methods. The ACM data used for our modelling come from various sources including nominated country focal points and public-facing databases, and can be characterized according to three criteria: whether the data are nationally representative, what proportion of the two-year pandemic period they cover and the time periods to which the data are aggregated. By region, the monthly data that are available consist of only 6 out of the 47 countries in the Africa region (13%), 23 out of the 35 countries from the region of the Americas (66%), 9 out of the 21 countries from the Eastern Mediterranean region (43%), 51 out of the 53 countries in the European region (96%), 2 out of 11 countries in the South East Asia region (18%) and 9 out of 27 countries in the Western Pacific region (33%). There are 10 countries with subnational or annual data; 4 are from the region of the Americas, 1 from the European region, 3 from the South East Asia region and 2 from the Western Pacific region. We use a Bayesian Poisson framework to estimate both the expected deaths (for all countries and all months) in the absence of the pandemic, and the ACM for those countries with no such data during the pandemic. In addition to the data on ACM, we gathered information on specific variables with spatiotemporal variations considered to be associated with changes in excess mortality

Read the complete text